Gene-activated Matrix for Bone Tissue Repair in Maxillofacial Surgery

Exclusion Criteria

• •not able or unwilling to give voluntary informed consent for the study or follow requirements of the clinical study;
• •decompensated chronic visceral diseases;
• •clinically significant laboratory abnormalities;
• •HIV, HBV and HCV antibodies in serum;
• •alcohol consumption within 4 days prior the study;
• •history of drug addiction;
• •participation in other clinical studies (or administration of study products) within 3 months prior the study;
• •conditions limiting study compliance (dementia, psycho-neurological diseases, drug addiction, alcoholism, etc.);
• •malignancies including post-surgical period with chemo- and (or) radiation therapy);
• •vascular malformations;
• •pregnancy or lactation.